Empagliflozin and its impact on hepatic and metabolic outcomes in patients with type 2 diabetes and NAFLD: a systematic review and meta-analysis.

Diabetol Metab Syndr · 2026 · PMC12879374 · PMID 41508110

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

contributed the majority of the weight (83.2%) to the analysis, the results did not reach statistical significance.

also in 111,027 other papers

a nonsignificant trendno p-value reported

The pooled analysis showed a nonsignificant trend toward lower GGT levels; however, the results were highly variable across studies.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.